Repetitive levosimendan infusions for patients with advanced chronic heart failure in the vulnerable post‐discharge period

Hospitalization for acute heart failure (HF) is associated with a substantial morbidity burden and with associated healthcare costs and an increased mortality risk. However, few if any major medical innovations have been witnessed in this area in recent times. Levosimendan is a first‐in‐class calciu...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:ESC Heart Fail
Autors principals: Pölzl, Gerhard, Allipour Birgani, Shadab, Comín‐Colet, Josep, Delgado, Juan F., Fedele, Francesco, García‐Gonzáles, Martín Jesús, Gustafsson, Finn, Masip, Josep, Papp, Zoltán, Störk, Stefan, Ulmer, Hanno, Vrtovec, Bojan, Wikström, Gerhard, Altenberger, Johann
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2018
Matèries:
Study Designs
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6351894/
https://ncbi.nlm.nih.gov/pubmed/30378288
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ehf2.12366
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars